| Preston A Waters, MD | |
|
1324 N Harville Rd, Duncan, OK 73533-1514 | |
| (580) 252-1373 | |
| Not Available |
| Full Name | Preston A Waters |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 27 Years |
| Location | 1324 N Harville Rd, Duncan, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356341457 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 21773 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Duncan Regional Hospital Homecare | Duncan, OK | Home health agency |
| Health Watch Health Care Of Duncan, Llc | Duncan, OK | Home health agency |
| Duncan Regional Hospital, Inc | Duncan, OK | Hospital |
| Jefferson County Hospital | Waurika, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Duncan Regional Hospital, Inc. | 5193613057 | 31 |
| Solutions Practice Management | 5698840775 | 33 |
News Archive
The Translational Genomics Research Institute (TGen) is part of a team of medical investigators receiving a $3.5 million grant from Susan G. Komen for the Cure to study triple-negative breast cancer, a highly aggressive form of this cancer that disproportionately affects African-Americans.
NeuroPace, Inc. today announced that the U.S. Food and Drug Administration has granted premarket approval for the NeuroPace RNS System, a treatment for adults with partial onset seizures that have not been controlled with two or more antiepileptic drugs.
Elaine Katz, MS, CCC-SLP, of Kessler Foundation will speak at "Building a More Inclusive Workforce: A National Summit to Boost Education and Employment Outcomes for Americans with Disabilities."
Cegedim Dendrite today announced that LEO Pharma has implemented Mobile Intelligence™, Cegedim Dendrite's flagship Customer Relationship Management (CRM) solution using a Software as a Service (SaaS) delivery model, in six countries in the Asia-Pacific region. LEO Pharma is a global pharmaceutical company specializing in dermatology and critical care and Cegedim Dendrite is the world's leading provider of Pharmaceutical CRM solutions with a 35 percent global market share.
Align Technology, Inc. today announced that it has reached a settlement with Ormco Corporation (Ormco), a subsidiary of Danaher Corporation, to end all pending litigation between the parties and to begin a new strategic collaboration.
› Verified 1 days ago
| Entity Name | Solutions Practice Management |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104009299 PECOS PAC ID: 5698840775 Enrollment ID: O20081015000361 |
News Archive
The Translational Genomics Research Institute (TGen) is part of a team of medical investigators receiving a $3.5 million grant from Susan G. Komen for the Cure to study triple-negative breast cancer, a highly aggressive form of this cancer that disproportionately affects African-Americans.
NeuroPace, Inc. today announced that the U.S. Food and Drug Administration has granted premarket approval for the NeuroPace RNS System, a treatment for adults with partial onset seizures that have not been controlled with two or more antiepileptic drugs.
Elaine Katz, MS, CCC-SLP, of Kessler Foundation will speak at "Building a More Inclusive Workforce: A National Summit to Boost Education and Employment Outcomes for Americans with Disabilities."
Cegedim Dendrite today announced that LEO Pharma has implemented Mobile Intelligence™, Cegedim Dendrite's flagship Customer Relationship Management (CRM) solution using a Software as a Service (SaaS) delivery model, in six countries in the Asia-Pacific region. LEO Pharma is a global pharmaceutical company specializing in dermatology and critical care and Cegedim Dendrite is the world's leading provider of Pharmaceutical CRM solutions with a 35 percent global market share.
Align Technology, Inc. today announced that it has reached a settlement with Ormco Corporation (Ormco), a subsidiary of Danaher Corporation, to end all pending litigation between the parties and to begin a new strategic collaboration.
› Verified 1 days ago
| Entity Name | Hcc Duncan Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013153543 PECOS PAC ID: 1759447873 Enrollment ID: O20090225000497 |
News Archive
The Translational Genomics Research Institute (TGen) is part of a team of medical investigators receiving a $3.5 million grant from Susan G. Komen for the Cure to study triple-negative breast cancer, a highly aggressive form of this cancer that disproportionately affects African-Americans.
NeuroPace, Inc. today announced that the U.S. Food and Drug Administration has granted premarket approval for the NeuroPace RNS System, a treatment for adults with partial onset seizures that have not been controlled with two or more antiepileptic drugs.
Elaine Katz, MS, CCC-SLP, of Kessler Foundation will speak at "Building a More Inclusive Workforce: A National Summit to Boost Education and Employment Outcomes for Americans with Disabilities."
Cegedim Dendrite today announced that LEO Pharma has implemented Mobile Intelligence™, Cegedim Dendrite's flagship Customer Relationship Management (CRM) solution using a Software as a Service (SaaS) delivery model, in six countries in the Asia-Pacific region. LEO Pharma is a global pharmaceutical company specializing in dermatology and critical care and Cegedim Dendrite is the world's leading provider of Pharmaceutical CRM solutions with a 35 percent global market share.
Align Technology, Inc. today announced that it has reached a settlement with Ormco Corporation (Ormco), a subsidiary of Danaher Corporation, to end all pending litigation between the parties and to begin a new strategic collaboration.
› Verified 1 days ago
| Entity Name | Duncan Regional Hospital, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699318147 PECOS PAC ID: 5193613057 Enrollment ID: O20200930003440 |
News Archive
The Translational Genomics Research Institute (TGen) is part of a team of medical investigators receiving a $3.5 million grant from Susan G. Komen for the Cure to study triple-negative breast cancer, a highly aggressive form of this cancer that disproportionately affects African-Americans.
NeuroPace, Inc. today announced that the U.S. Food and Drug Administration has granted premarket approval for the NeuroPace RNS System, a treatment for adults with partial onset seizures that have not been controlled with two or more antiepileptic drugs.
Elaine Katz, MS, CCC-SLP, of Kessler Foundation will speak at "Building a More Inclusive Workforce: A National Summit to Boost Education and Employment Outcomes for Americans with Disabilities."
Cegedim Dendrite today announced that LEO Pharma has implemented Mobile Intelligence™, Cegedim Dendrite's flagship Customer Relationship Management (CRM) solution using a Software as a Service (SaaS) delivery model, in six countries in the Asia-Pacific region. LEO Pharma is a global pharmaceutical company specializing in dermatology and critical care and Cegedim Dendrite is the world's leading provider of Pharmaceutical CRM solutions with a 35 percent global market share.
Align Technology, Inc. today announced that it has reached a settlement with Ormco Corporation (Ormco), a subsidiary of Danaher Corporation, to end all pending litigation between the parties and to begin a new strategic collaboration.
› Verified 1 days ago
| Entity Name | Duncan Regional Hospital, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942918214 PECOS PAC ID: 5193613057 Enrollment ID: O20230701000000 |
News Archive
The Translational Genomics Research Institute (TGen) is part of a team of medical investigators receiving a $3.5 million grant from Susan G. Komen for the Cure to study triple-negative breast cancer, a highly aggressive form of this cancer that disproportionately affects African-Americans.
NeuroPace, Inc. today announced that the U.S. Food and Drug Administration has granted premarket approval for the NeuroPace RNS System, a treatment for adults with partial onset seizures that have not been controlled with two or more antiepileptic drugs.
Elaine Katz, MS, CCC-SLP, of Kessler Foundation will speak at "Building a More Inclusive Workforce: A National Summit to Boost Education and Employment Outcomes for Americans with Disabilities."
Cegedim Dendrite today announced that LEO Pharma has implemented Mobile Intelligence™, Cegedim Dendrite's flagship Customer Relationship Management (CRM) solution using a Software as a Service (SaaS) delivery model, in six countries in the Asia-Pacific region. LEO Pharma is a global pharmaceutical company specializing in dermatology and critical care and Cegedim Dendrite is the world's leading provider of Pharmaceutical CRM solutions with a 35 percent global market share.
Align Technology, Inc. today announced that it has reached a settlement with Ormco Corporation (Ormco), a subsidiary of Danaher Corporation, to end all pending litigation between the parties and to begin a new strategic collaboration.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Preston A Waters, MD 2515 W Elk Ave, Duncan, OK 73533-1571 Ph: (580) 252-6080 | Preston A Waters, MD 1324 N Harville Rd, Duncan, OK 73533-1514 Ph: (580) 252-1373 |
News Archive
The Translational Genomics Research Institute (TGen) is part of a team of medical investigators receiving a $3.5 million grant from Susan G. Komen for the Cure to study triple-negative breast cancer, a highly aggressive form of this cancer that disproportionately affects African-Americans.
NeuroPace, Inc. today announced that the U.S. Food and Drug Administration has granted premarket approval for the NeuroPace RNS System, a treatment for adults with partial onset seizures that have not been controlled with two or more antiepileptic drugs.
Elaine Katz, MS, CCC-SLP, of Kessler Foundation will speak at "Building a More Inclusive Workforce: A National Summit to Boost Education and Employment Outcomes for Americans with Disabilities."
Cegedim Dendrite today announced that LEO Pharma has implemented Mobile Intelligence™, Cegedim Dendrite's flagship Customer Relationship Management (CRM) solution using a Software as a Service (SaaS) delivery model, in six countries in the Asia-Pacific region. LEO Pharma is a global pharmaceutical company specializing in dermatology and critical care and Cegedim Dendrite is the world's leading provider of Pharmaceutical CRM solutions with a 35 percent global market share.
Align Technology, Inc. today announced that it has reached a settlement with Ormco Corporation (Ormco), a subsidiary of Danaher Corporation, to end all pending litigation between the parties and to begin a new strategic collaboration.
› Verified 1 days ago
Dan F Criswell, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2601 W Elk Ave, Duncan, OK 73533 Phone: 580-251-6644 Fax: 580-251-6645 | |
Krystal Marie Vonfeldt, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2120 W Elk Ave, Duncan, OK 73533 Phone: 580-251-6822 | |
William T Stewart, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1324 N Harville Rd, Duncan, OK 73533 Phone: 580-252-1373 Fax: 580-252-8336 | |
Francis James Mcgouran Iii, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1334 N Harville Rd, Duncan, OK 73533 Phone: 580-255-8564 Fax: 580-255-8640 | |
Demetra G Cox, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1324 N Harville Rd, Duncan, OK 73533 Phone: 580-252-1373 Fax: 580-252-8336 | |
Dr. Mark Rosekelly, D.O Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 4086 Country Club Rd Ste 2, Duncan, OK 73533 Phone: 580-952-9221 |